Erika Augustine is a Neurology physician. OpenAlex indexes 135 publications with 2,587 citations (h-index 24); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingClinical trials
- Cellcept for Treatment of Juvenile Neuronal Ceroid Lipofuscinosis
Sponsor: University of Rochester
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- PTC TherapeuticsProgram year20241 paymentResearch
- PTC TherapeuticsProgram year20232 paymentsResearch
- PTC TherapeuticsProgram year20229 paymentsResearch$12,500openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward. Research funding is listed under each investigator the record names.
NIH funding
2 NIH research awards on record, funded 2013–2024 per NIH RePORTER. The latest:
- Meaningful Outcomes and Multi-Site Readiness for Clinical Trials in Juvenile Neuronal Ceroid Lipofuscinosis
University of Rochester
FY2024$610,733U01NS101946 - Meaningful Outcomes and Multi-Site Readiness for Clinical Trials in Juvenile Neuronal Ceroid Lipofuscinosis
University of Rochester
FY2023$707,937U01NS101946 - Meaningful Outcomes and Multi-Site Readiness for Clinical Trials in Juvenile Neuronal Ceroid Lipofuscinosis
University of Rochester
FY2021$745,729U01NS101946
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- From roadmap to a sustainable end-to-end individualized therapy pathway
Therapeutic Advances in Rare Disease
2025 - The state-of-the-art of N-of-1 therapies and the IRDiRC N-of-1 development roadmap
Nature Reviews Drug Discovery
2024 - A framework for N-of-1 trials of individualized gene-targeted therapies for genetic diseases
Nature Communications
2024 - The parent and family impact of CLN3 disease: an observational survey-based study
Orphanet Journal of Rare Diseases
2024
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Bruce Miller, MD
University of California, San Francisco (UCSF)
Brett Kissela, MD
Medical College of Wisconsin
Richard Lipton, MD
Albert Einstein College of Medicine
Bradley Boeve, MD
Mayo Clinic
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”